Clonazepam 0.5mg Taper Recommendation
For clonazepam 0.5mg, taper by reducing the dose by 0.125mg (one-quarter tablet) every 1-2 weeks until discontinuation, which typically takes 6-8 weeks for this low dose. 1
Tapering Protocol
The FDA-approved prescribing information for Klonopin (clonazepam) specifically states that treatment should be discontinued gradually, with a decrease of 0.125mg twice daily every 3 days for panic disorder 1. However, for patients on long-term therapy (which applies to most benzodiazepine users), a more conservative approach is warranted.
Specific Taper Schedule for 0.5mg Daily Dose:
Week 1-2: 0.375mg daily (reduce by 0.125mg)
Week 3-4: 0.25mg daily (reduce by another 0.125mg)
Week 5-6: 0.125mg daily (reduce by another 0.125mg)
Week 7-8: Discontinue
If the patient experiences significant withdrawal symptoms (anxiety, insomnia, tremor, sweating, or agitation), pause the taper at the current dose for 1-2 additional weeks before proceeding 2, 1.
Evidence-Based Rationale
Research demonstrates that clonazepam can be successfully discontinued without major withdrawal symptoms when the dose is reduced gradually. A study of 73 patients with panic disorder who had been on clonazepam for at least 3 years showed that reducing by 0.25mg per week after reaching 1mg/day was well-tolerated, with 68.9% successfully discontinuing within 4 months 3. Since your dose is already 0.5mg, the proportionally slower taper of 0.125mg every 1-2 weeks is appropriate.
The 2016 CDC guideline on benzodiazepine tapering (in the context of concurrent opioid use) recommends a 25% dose reduction every 1-2 weeks as a commonly used schedule that has been used safely with moderate success 2. For a 0.5mg dose, this translates to approximately 0.125mg reductions.
Critical Safety Considerations
- Never stop abruptly: Benzodiazepine withdrawal can cause rebound anxiety, hallucinations, seizures, delirium tremens, and rarely death 2
- Monitor for withdrawal symptoms: Anxiety, insomnia, tremor, sweating, tachycardia, nausea, headache, muscle aches 3
- Slower is safer: If withdrawal symptoms emerge, the taper rate should be slowed further 1
- Tolerance loss: After discontinuation, there is increased risk of overdose if the medication is restarted at the previous dose due to loss of tolerance 1
Adjunctive Support
Consider cognitive behavioral therapy (CBT) during the taper, as it increases tapering success rates and is particularly helpful for patients struggling with benzodiazepine discontinuation 2. Address any underlying anxiety with evidence-based psychotherapies or non-benzodiazepine medications if needed 2.
Follow-Up Schedule
Monitor the patient at least monthly during the taper, though more frequent contact (every 1-2 weeks) is preferable for this relatively short taper 4. Telephone contact or telehealth visits can supplement in-person visits 4.